Bicocca Open Archive

Logo unimib boa

Fabbri, C., Crisafulli, C., Gurwitz, D., Stingl, J., Calati, R., Albani, D., et al. (2015). Neuroplasticity and Second Messenger Pathways in Antidepressant Efficacy: Pharmacogenetic Results from a Prospective Trial Investigating Treatment Resistance. In The 14th Annual Pharmacogenetics in Psychiatry Meeting, Conference Proceedings (pp.63-64).

Neuroplasticity and Second Messenger Pathways in Antidepressant Efficacy: Pharmacogenetic Results from a Prospective Trial Investigating Treatment Resistance

Calati R;
2015
abstract
Antidepressant; Gene; Neuroplasticity; Pharmacogenetics; Polymorphism; Treatment-resistant depression
English
The 14th Annual Pharmacogenetics in Psychiatry Meeting
October 15
The 14th Annual Pharmacogenetics in Psychiatry Meeting, Conference Proceedings
2015
63
64
http://www.pharmacogeneticsinpsychiatry.com/images/PIP_ProgramBook_2015.pdf
none
Fabbri, C., Crisafulli, C., Gurwitz, D., Stingl, J., Calati, R., Albani, D., et al. (2015). Neuroplasticity and Second Messenger Pathways in Antidepressant Efficacy: Pharmacogenetic Results from a Prospective Trial Investigating Treatment Resistance. In The 14th Annual Pharmacogenetics in Psychiatry Meeting, Conference Proceedings (pp.63-64).
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/247337
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact